Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - cardiovascular - immunoassay for the in vitro quantitative determination of myoglobin in human serum and plasma. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys and cobas e immunoassay analyzers.

Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - roche diagnostics elecsys n-mid osteocalcin is an immunoassay for the in vitro quantitative determination of n-mid osteocalcin in human serum and plasma. the determination is used for the control of antiresorptives therapeutic efficiency, e.g. for patients with osteoporosis or hypercalcemia. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys and cobas e immunoassay analyzers.

Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - immunoassay for the in vitro quantitative determination of placental growth factor (plgf) in human serum. the plgf assay is used in combination with the elecsys sflt‑1 assay to determine the sflt‑1/plgf ratio. the sflt‑1/plgf ratio is intended for use as an aid in the diagnosis of preeclampsia in conjunction with other diagnostic and clinical information. in addition the sflt‑1/plgf ratio is intended for use as an aid in short-term prediction of preeclampsia (rule-out and rule-in) in pregnant women with suspicion of preeclampsia in conjunction with other diagnostic and clinical information. this assay is intended for the use as one component, in combination with other parameters, to evaluate the risk of early-onset preeclampsia during the first trimester of pregnancy. the electrochemiluminescence immunoassay “eclia” is intended for use on cobas e immunoassay analyzers.

Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - roche diagnostics elecsys pth is an immunoassay for the in vitro quantitative determination of intact parathyroid hormone in human serum and plasma for the differential diagnosis of hypercalcemia and hypocalcemia. this assay can be used intraoperatively. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys and cobas e immunoassay analyzers.

Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - roche diagnostics elecsys pth (1-84) is an immunoassay for the in vitro quantitative determination of biointact parathyroid hormone, pth (1-84) in human serum and plasma for the differential diagnosis of hypercalcemia and hypocalcemia. this assay can be used intraoperatively. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys and cobas e immunoassay analyzers.

Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - roche diagnostics elecsys pth stat is an immunoassay for the in vitro quantitative determination of intact parathyroid hormone in human serum and plasma for the differential diagnosis of hypercalcemia and hypocalcemia. the elecsys pth stat assay can be used intraoperatively. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys and cobas e immunoassay analyzers.

Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - pathology - immunoassay for the in vitro quantitative determination of s100 (s100 a1b and s100 bb) in human serum. the elecsys s100 assay can be used • to aid in the management of patients suffering from malignant melanoma (elecsys s100 assay is not suitable for the diagnosis of malignant melanoma) • to aid in the management of patients after potential brain injury in conjunction with clinical information and imaging techniques. the electrochemiluminescence immunoassay “eclia” is intended for use on cobas e immunoassay analyzers.

Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - immunoassay for the in vitro quantitative determination of soluble fms‑like tyrosine kinase‑1 (sflt‑1) in human serum. the elecsys sflt‑1 assay is used in combination with the elecsys plgf assay to determine the sflt‑1/plgf ratio. the sflt‑1/plgf ratio is intended for use as an aid in the diagnosis of preeclampsia in conjunction with other diagnostic and clinical information. in addition the sflt‑1/plgf ratio is intended for use as an aid in short-term prediction of preeclampsia (rule-out and rule-in) in pregnant women with suspicion of preeclampsia in conjunction with other diagnostic and clinical information. the electrochemiluminescence immunoassay “eclia” is intended for use on cobas e immunoassay analyzers.

Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - roche diagnostics elecsys total p1np is an immunoassay for the in vitro quantitative determination of total p1np in human serum and plasma. this assay is intended for use in monitoring therapy following the diagnosis of osteoporosis in post-menopausal women and in patients diagnosed with paget’s disease of the bone. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys and cobas e immunoassay analyzers.

Singapura - Inggris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - immunoassay for the in vitro quantitative determination of igg antibodies to toxoplasma gondii in human serum and plasma. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys and cobas e immunoassay analyzers.